To restate: Samsung gave CytoDyn a $34m loan of at least a year's duration via "non-standard payment terms." Admittedly there could be costs we don't know, but presumably much, much better than Fife.

Never know what will show up in the notes (#4 and #10) to the financial statements! Amazing news, both on immediate cash flow and as a vote of confidence. Stoked!